Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2ά mutation

Blood

Volumn 112, Issue 3, 2008, Pages 919-921

  Gale, Daniel P ^b   Harten, Sarah K ^b   Reid, Cecil D L ^b   Tuddenham, Edward G D ^b   Maxwell, Patrick H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

AUTOSOMAL DOMINANT DISORDER; ERYTHROCYTOSIS; GENE MUTATION; GENOME; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; ADOLESCENT; ADULT; AGED; GENETICS; MIDDLE AGED; MUTATION; POLYCYTHEMIA;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; MUTATION; POLYCYTHEMIA;

EID: 50949133897     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-153718     Document Type: Letter

References (10)

1. Ang SO, Chen H, Hirota K, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet. 2002;32:614-621.
2. Percy MJ, Zhao Q, Flores A, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci USA. 2006;103:654-659.
3. Percy MJ, Furlow PW, Lucas GS, et al. Again-of-function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med. 2008;358:162-168.
4. Howarth G, Chanarin I, Janowska-WieczorekA; et al. Familial erythrocytosis. Scand J Haematol. 1979;23:217-222.
5. Warnecke C, Zaborowska Z, Kurreck J, et al. Differentiating the functional role of hypoxia-inducible factor (HIF)-1 alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 2004;18:1462-1464.
6. Hickey MM, Lam JC, Bezman NA, et al. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. J Clin Invest. 2007;117:3879-3889.
7. Wiesener MS, Jurgensen JS, Rosenberger C, et al. Widespread hypoxiainducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 2003;17:271-273.
8. Smith TG, Brooks JT, Baianos GM, et al. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med. 2006;3:e290.
9. Bushuev VI, Miasnikova GY, Sergueeva AI. et al. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica. 2006;91:744-749.
10. Brusselmans K, Compernolle V, Tjwa M, et al. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest. 2003;111:1519-1527.